Medifast (MED +7.4%) trades up this morning after a solid Q3 report yesterday, and earlier set a...

|By:, SA News Editor

Medifast (MED +7.4%) trades up this morning after a solid Q3 report yesterday, and earlier set a 52-week high of $29.20 before tapering off. The company guided Q4 above Street consensus, now seeing EPS at $0.23 to $0.25 on revenue of $82M to $84M, beating expectations for $0.19 per share on $79M in revenue.